Kintor Pharmaceutical Ltd. received an emergency use authorization (EUA) for proxalutamide in the treatment of COVID-19 in Paraguay. There has been a great deal of skepticism…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.